535 related articles for article (PubMed ID: 28698273)
1. Viral MicroRNAs Repress the Cholesterol Pathway, and 25-Hydroxycholesterol Inhibits Infection.
Serquiña AKP; Kambach DM; Sarker O; Ziegelbauer JM
mBio; 2017 Jul; 8(4):. PubMed ID: 28698273
[TBL] [Abstract][Full Text] [Related]
2. 25-Hydroxycholesterol Inhibits Kaposi's Sarcoma Herpesvirus and Epstein-Barr Virus Infections and Activates Inflammatory Cytokine Responses.
Serquiña AKP; Tagawa T; Oh D; Mahesh G; Ziegelbauer JM
mBio; 2021 Dec; 12(6):e0290721. PubMed ID: 34781692
[TBL] [Abstract][Full Text] [Related]
3. Kaposi's Sarcoma-Associated Herpesvirus MicroRNAs Target GADD45B To Protect Infected Cells from Cell Cycle Arrest and Apoptosis.
Liu X; Happel C; Ziegelbauer JM
J Virol; 2017 Feb; 91(3):. PubMed ID: 27852859
[TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma-associated herpesvirus microRNAs repress breakpoint cluster region protein expression, enhance Rac1 activity, and increase in vitro angiogenesis.
Ramalingam D; Happel C; Ziegelbauer JM
J Virol; 2015 Apr; 89(8):4249-61. PubMed ID: 25631082
[TBL] [Abstract][Full Text] [Related]
5. Modified Cross-Linking, Ligation, and Sequencing of Hybrids (qCLASH) Identifies Kaposi's Sarcoma-Associated Herpesvirus MicroRNA Targets in Endothelial Cells.
Gay LA; Sethuraman S; Thomas M; Turner PC; Renne R
J Virol; 2018 Apr; 92(8):. PubMed ID: 29386283
[TBL] [Abstract][Full Text] [Related]
6. Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells.
Cai X; Lu S; Zhang Z; Gonzalez CM; Damania B; Cullen BR
Proc Natl Acad Sci U S A; 2005 Apr; 102(15):5570-5. PubMed ID: 15800047
[TBL] [Abstract][Full Text] [Related]
7. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.
Purushothaman P; Thakker S; Verma SC
J Virol; 2015 Mar; 89(6):3093-111. PubMed ID: 25552714
[TBL] [Abstract][Full Text] [Related]
8. Discovery of Kaposi's sarcoma herpesvirus-encoded circular RNAs and a human antiviral circular RNA.
Tagawa T; Gao S; Koparde VN; Gonzalez M; Spouge JL; Serquiña AP; Lurain K; Ramaswami R; Uldrick TS; Yarchoan R; Ziegelbauer JM
Proc Natl Acad Sci U S A; 2018 Dec; 115(50):12805-12810. PubMed ID: 30455306
[TBL] [Abstract][Full Text] [Related]
9. Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas.
Haecker I; Gay LA; Yang Y; Hu J; Morse AM; McIntyre LM; Renne R
PLoS Pathog; 2012; 8(8):e1002884. PubMed ID: 22927820
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway.
Lu F; Stedman W; Yousef M; Renne R; Lieberman PM
J Virol; 2010 Mar; 84(6):2697-706. PubMed ID: 20071580
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic Kaposi's Sarcoma-Associated Herpesvirus Upregulates Argininosuccinate Synthase 1, a Rate-Limiting Enzyme of the Citrulline-Nitric Oxide Cycle, To Activate the STAT3 Pathway and Promote Growth Transformation.
Li T; Zhu Y; Cheng F; Lu C; Jung JU; Gao SJ
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463977
[TBL] [Abstract][Full Text] [Related]
12. In-depth analysis of Kaposi's sarcoma-associated herpesvirus microRNA expression provides insights into the mammalian microRNA-processing machinery.
Umbach JL; Cullen BR
J Virol; 2010 Jan; 84(2):695-703. PubMed ID: 19889781
[TBL] [Abstract][Full Text] [Related]
13. Kaposi Sarcoma Herpesvirus Induces HO-1 during De Novo Infection of Endothelial Cells via Viral miRNA-Dependent and -Independent Mechanisms.
Botto S; Totonchy JE; Gustin JK; Moses AV
mBio; 2015 Jun; 6(3):e00668. PubMed ID: 26045540
[TBL] [Abstract][Full Text] [Related]
14. miRNAs and their roles in KSHV pathogenesis.
Hussein HAM; Alfhili MA; Pakala P; Simon S; Hussain J; McCubrey JA; Akula SM
Virus Res; 2019 Jun; 266():15-24. PubMed ID: 30951791
[TBL] [Abstract][Full Text] [Related]
15. Kaposi's sarcoma herpesvirus microRNAs induce metabolic transformation of infected cells.
Yogev O; Lagos D; Enver T; Boshoff C
PLoS Pathog; 2014 Sep; 10(9):e1004400. PubMed ID: 25255370
[TBL] [Abstract][Full Text] [Related]
16. Kaposi's sarcoma-associated herpesvirus encodes a mimic of cellular miR-23.
Manzano M; Shamulailatpam P; Raja AN; Gottwein E
J Virol; 2013 Nov; 87(21):11821-30. PubMed ID: 23986579
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9 ablating viral microRNA promotes lytic reactivation of Kaposi's sarcoma-associated herpesvirus.
Liang Z; Qin Z; Riker AI; Xi Y
Biochem Biophys Res Commun; 2020 Dec; 533(4):1400-1405. PubMed ID: 33092788
[TBL] [Abstract][Full Text] [Related]
18. microRNA dependent and independent deregulation of long non-coding RNAs by an oncogenic herpesvirus.
Sethuraman S; Gay LA; Jain V; Haecker I; Renne R
PLoS Pathog; 2017 Jul; 13(7):e1006508. PubMed ID: 28715488
[TBL] [Abstract][Full Text] [Related]
19. KSHV microRNAs: Tricks of the Devil.
Qin J; Li W; Gao SJ; Lu C
Trends Microbiol; 2017 Aug; 25(8):648-661. PubMed ID: 28259385
[TBL] [Abstract][Full Text] [Related]
20. Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.
Sanchez EL; Pulliam TH; Dimaio TA; Thalhofer AB; Delgado T; Lagunoff M
J Virol; 2017 May; 91(10):. PubMed ID: 28275189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
